Empirico
Omri Gottesman is the CEO of Empirico Inc., a biotechnology company focused on the discovery and development of novel medicines. Prior to their current role, Omri held positions at Regeneron Pharmaceuticals, Inc. as the Head of Clinical Informatics and at NHS England as a Medical Doctor focusing on Ambulatory Care and Acute Medicine. Omri also served as an Assistant Professor of Medicine at Icahn School of Medicine at Mount Sinai and completed a Fellowship in Personalized Medicine. Omri earned a Doctor of Medicine degree from UCL and a BSc in Pharmacology.
This person is not in any teams
Empirico
1 followers
Empirico is a biotechnology company focused on the discovery and development of novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease. Empirico’s two foundational and proprietary technology platforms - the Precision Insights Platform™ for genetically-validated target discovery and siRCH™ for the discovery and development of siRNA medicines - are used separately and in tandem to enable Empirico and our collaborators from the discovery and validation of novel targets to the development of clinically-viable therapeutics. Empirico’s exceptional internal capabilities, augmented by those of its partners, are driving the advancement of a growing and differentiated pipeline of wholly-owned and partnered programs. Empirico is headquartered in San Diego, CA with a major second site in Madison, WI.